PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.74%
Some net income increase while BB is negative at -12275.00%. John Neff would see a short-term edge over the struggling competitor.
9.16%
Some D&A expansion while BB is negative at -28.57%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-12.72%
Negative yoy deferred tax while BB stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-1.99%
Negative yoy SBC while BB is 37.50%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
130.22%
Well above BB's 106.10% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-698.58%
AR is negative yoy while BB is 152.38%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
252.83%
Inventory growth of 252.83% while BB is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
422.11%
AP growth well above BB's 200.00%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
288.57%
Growth well above BB's 97.22%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
210.00%
Lower 'other non-cash' growth vs. BB's 907.27%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
17.71%
Operating cash flow growth below 50% of BB's 94.65%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-35.36%
Both yoy lines negative, with BB at -1100.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-13.29%
Negative yoy acquisition while BB stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-32.14%
Both yoy lines negative, with BB at -1.67%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-13.88%
We reduce yoy sales while BB is 33.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
84.05%
Growth well above BB's 97.84%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-179.84%
We reduce yoy invests while BB stands at 455.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-4.48%
Both yoy lines negative, with BB at -97.97%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-3.54%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.